Nuzenio

Fosun Pharma Subsidiary

Fosun Pharma Subsidiary news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Fosun Pharma Subsidiary Wins China Approval for Heart Failure Injection - TipRanksTipRanks · Sat, 08 Aug 2026 05:38:24 GMTFosun Pharma Wins NMPA Approval for New Levosalbutamol Nebuliser Therapy - TipRanksTipRanks · Sat, 08 Aug 2026 02:25:21 GMTFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 10:26:00 GMTFosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in China - TipRanksTipRanks · Mon, 03 Aug 2026 10:52:46 GMTFosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 05:38:24 GMTFosun Pharma Subsidiary Wins China Approval for Heart Failure Injection - TipRanks
Sat, 08 Aug 2026 02:25:21 GMTFosun Pharma Wins NMPA Approval for New Levosalbutamol Nebuliser Therapy - TipRanks
Tue, 04 Aug 2026 10:26:00 GMTFosun Pharma Subsidiary Wins Approval for New Type 2 Diabetes Combination Drug - The Globe and Mail
Mon, 03 Aug 2026 10:52:46 GMTFosun Pharma Subsidiary Wins Approval for Pediatric Constipation Drug in China - TipRanks
Wed, 29 Jul 2026 07:00:00 GMTFosun International Issues Positive Profit Alert: Profit Attributable to Owners of the Parent for 1H2026 Expected to be Approx. RMB 1.5 Billion to RMB1.8 Billion - The Manila Times

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Fosun Pharma Subsidiary.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.